A financial Media and CBDOil company for Chinese customers on the rise, with a price target of 3.75 $ by See Thru Equity.

Interview:
Cannanet.eu with Warren Wang, CEO of ChineseInvestors.com

 

  1. Mr. Wang, Chineseinvestors.com has been in the Media business since 1999, how has the company evolved since then?

    ChineseInvestors.com, Inc. primary objective is to be THE leading financial information website providing real-time market commentary and analysis specifically for Chinese-speaking investors via our company’s dynamic financial website, www.chinesefn.com. We have our own financial information mobile application as well. In the past 18 years, we have acquired more than 100,000 registered users. Our business model incorporates the use of traditional media revenue sources as well as advertising revenue. Morningstar Research has noted that the average annual growth rate of CIIX during the last five years is more than 150%. Our headquarters is currently located in Los Angeles, California, and we have 60 employees in total including staff in New York and Shanghai.

  2. Your company aims at the Chinese speaking population of the USA and to the Chinese public in general. How do you reach your audience and what are your most popular broadcasts?

    We reach our Chinese-speaking audience in North America through mass media and advertisements. We have close cooperative partnerships with various media channels including Phoenix TV North America. We also launched the first ever US stock TV show “Wall Street Gold Miner” with China Business Network (CBN) in Shanghai, China. CIIX has become a very authoritative and trustworthy resource for the Chinese-speaking investment community during our 18 year history, and we continue to add new users on a monthly basis.

  3. CIIX is also now becoming an investment company of its own as you have launched www.chineseCBDoil.com to market CBD Oil Products in China. What is the Hemp & Cannabis situation in general in China? What can be sold and what is illegal there?

CBD is not legal in China. However, hemp is legal and can be made into energy bars, hemp seeds and other health products. In the near future, we will launch a series of cosmetic products containing CBD since its use in skin care products is legal in China. We believe that once we launch these and other products in China that contain high-tech extracted and purified hemp , that CIIX will also draw the attention of Chinese communities all over the United States and the rest of the world.

  1. Selling CBD Oil Products in China can be a big business opportunity?

    If and when CBD becomes fully legal in China, we think it will develop into a market of a few billion, or even tens of billions dollars in size.
    Why would we say that? Because one of the most important functions of CBD is that it can be used as a sedative. And although we cannot guarantee that CBD will be a cure for cancer or epilepsy, it will definitely be helpful for those patients suffering with these ailments.

    In China, there are more than 7,000 people dying of cancer every single day. Although CBD is still not legal in China, cancer patients will try every possible way to alleviate their pain, such as seek treatment methods abroad or ask their friends to purchase CBD on their behalf. China also has nearly 10 million epilepsy patients and CBD has been shown to be very effective in treating epilepsy according to a series of documentaries televised on CNN. As as result, the market for CBD will be huge!

    In order to meet the legitimate needs of both the US and the Chinese markets, we have established two separate websites, www.chinesehempoil.com and www.chinesecbdoil.com and we will soon open our first retail store in San Gabriel, California.

  2. Are you planning any more investments in the Hemp & Cannabis related sector?

    Yes. CIIX aspires to become a leading Chinese medical cannabis company. Currently, both CBD and medical marijuana are not legal in China, yet there does exist a potential great opportunity for CIIX. We do not expect that the Chinese government will legalize cannabis, as the government still does not permit casinos in mainland China today.

    However, medical cannabis has shown to be significantly effective in treating cancer and epilepsy. Therefore, we believe as Chinese people get sufficient medical education, they will go abroad to Germany, the U.S. or Canada to receive medical cannabis treatment and to buy CBD health products. This provides CIIX a huge opportunity in the future in providing services to these visiting patients overseas from mainland China.

  3. In December you completed a private placement with investors for 5 Mil Dollars... What are you planning to do with the money raised?

    We completed a $5 million private placement at the beginning of year 2017. In addition to continuing investing in our media business, we will invest most of our proceeds in our new hemp and CBD businesses. We officially established and registered XiBiDi Biotechnology Co., Ltd. in the Pudong Free-Trade Area in Shanghai, China, which is a 100% owned subsidiary of CIIX and can do business in

China. We believe XiBiDi Biotechnology will contribute substantial revenues for CIIX in FY2018. Currently, we are looking for the right CEO to run this new subsidiary, and we will announce our choice for that role in the near future.

In addition, we will also invest the proceeds towards creating our own hemp and CBD health products and to establish our own retail stores and chain stores. We will continue to invest in our medical cannabis ‘Yelp’ style website and mobile application in the Chinese language to help Chinese patients overcome the language barriers in the U.S and receive the medical cannabis treatments they desire. We endeavor to become the Chinese version of Weedmap and even to surpass it.

  1. Quarterly revenues of CIIX seem to be rising fast, do you expect this trend to continue?

    Our management team is very optimistic about our potential revenue growth for FY2018, and they expect our potential hemp-related revenues to reach eight digits in FY2020. This is also our long-term goal. We will continue to focus more on the marketing and retail of CBD and hemp products in FY2018. And for FY2018, we expect to reach a YoY revenue growth rate of more than 100%.

  2. Cannabis will become legal in Canada next year, are you also preparing to take part in this big market opportunity?

    Canada is the first G7 country to legalize cannabis nationwide. I am currently in Toronto participating in a cannabis exhibition, and everyone here is very passionate about cannabis. We hope have CIIX listed on a Canadian Exchange in the near future.

  3. Europe is also moving ahead with the legalization of Cannabis...Germany has recently made Cannabis legal for medical use...Any plans to move into the European market?

    We participated the Invest Exhibition in Stuttgart, Germany, and we have our own IR company in Germany as well. We anticipate entering the medical cannabis market in Germany and Europe, and I will personally visit Germany very soon.

10. Is CIIX looking at other promising businesses, like Nanotechnology, Robotics, Biotech or others?

We want to enter any market that can make money, but our focus is limited. We have studied the medical cannabis industry for more than three years. Our goal right now is to become the leading Chinese company in the medical cannabis industry and we will be laser-focused on this target. We appreciate the German people, and especially their dedicated spirit. CIIX brings that same spirit of dedication to our new venture in the medical cannabis industry. Thank you. 

CIIXChinesinvestors.com

www.chineseFN.com
www.chineseCBDOil.com

 

Disclaimer: All information contained herein as well as on the Cannanet.eu website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of Cannanet.eu and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. Cannanet.eu has motivation by means of either self-marketing or Cannanet.eu has been compensated by or for a company or companies discussed in this article. Please consult an investment professional before investing in anything viewed within. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the Cannanet.eu website.